Bristol Myers Squibb: the value of immuno-oncology in serving patients
Bristol Myers Squibb (BMS), a leading biopharmaceutical company, held a press conference in Cyprus on June 9, 2026, during which distinguished medical oncologists highlighted the key factors for improving cancer patient care. ...